Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate SAGE-217 in Participants With Essential Tremor

ClinicalTrials.gov ID: NCT02978781

Public ClinicalTrials.gov record NCT02978781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 9:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of SAGE-217 in the Treatment of Subjects With Essential Tremor

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a three-part, multicenter, Phase 2a study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of SAGE-217 in adult participants with essential tremor.

Study identification

NCT ID
NCT02978781
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biogen
Industry
Enrollment
34 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 24, 2017 (Actual)
Primary completion
Nov 22, 2017 (Actual)
Completion
Dec 5, 2017 (Actual)
Last update posted
Nov 28, 2023

2017

United States locations

U.S. sites
26
U.S. states
12
U.S. cities
26
Facility City State ZIP Site status
Sage Investigational Site Anniston Alabama 36207 —
Sage Investigational Site Little Rock Arkansas 72211 —
Sage Investigational Site Rogers Arkansas 72758 —
Sage Investigational Site Cerritos California 90703 —
Sage Investigational Site Fountain Valley California 92708 —
Sage Investigational Site Oceanside California 92056 —
Sage Investigational Site San Diego California 92103 —
Sage Investigational Site Englewood Colorado 80113 —
Sage Investigational Site Clearwater Florida 33756 —
Sage Investigational Site DeLand Florida 32720 —
Sage Investigational Site Lauderdale Lakes Florida 33319 —
Sage Investigational Site Orlando Florida 32806 —
Sage Investigational Site Ormond Beach Florida 32174 —
Sage Investigational Site St. Petersburg Florida 33713 —
Sage Investigational Site Tampa Florida 33612 —
Sage Investigational Site Atlanta Georgia 30331 —
Sage Investigational Site Decatur Georgia 30030 —
Sage Investigational Site Chicago Illinois 60612 —
Sage Investigational Site Urbana Illinois 61801 —
Sage Investigational Site Springfield Missouri 65802 —
Sage Investigational Site St Louis Missouri 63141 —
Sage Investigational Site Raleigh North Carolina 27612 —
Sage Investigational Site Cincinnati Ohio 45212 —
Sage Investigational Site Dayton Ohio 45417 —
Sage Investigational Site Nashville Tennessee 37232 —
Sage Investigational Site Fort Worth Texas 76104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02978781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 28, 2023 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02978781 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →